[toxnews] Toxicology Case Conference 4/7/22 (New York City Poison Control Center April 2022 Consultants' Conference)

[Christine Stork]

Please join us as we attend the NYC Consultants Case Conference this Thursday 4/7/2022
Please note Time change
1-4 PM



FLYER WITH REGISTRATION INFORMATION BELOW

(Syracuse rotators - please independently register)



"Updates in Inhalant Abuse"


Heather Long, MD
Professor of Emergency Medicine
Albany Medical College
Medical Director, Emergency Department
Chief, Division of Medical
Albany Medical Center
Albany, NY



Consultants' Conference will take place from 2 PM - 4 PM EST.



We will be broadcasting both the Grand Rounds lecture and Consultants' Conference via the same link on WebEx and there WILL NOT be a live conference at the Public Health Laboratory. Please click here<https://urldefense.com/v3/__https:/survey.alchemer.com/s3/5971719/Consultant-Conference?eventid=a1Q4V00002Vnf1gUAB&programname=NYC*20poison*20control&center__;JSU!!GobTDDpD7A!eMU4x8EzOhC_LWRkYKqMzRSVq8gsXTiv1ZETD5jEmo-9xFFTwjfD7xgTwHlhqich$> to register and download the WebEx outlook file.



Please Note: If you would like to receive this monthly announcement on a regular basis, please register for the conference at the link above, even if you are unable to attend.


Please post and distribute.
All are welcome.



Cases to be discussed for Consultants' Conference include:





1.     A 2-year-old child presents to the ED for evaluation after biting into what appears to be a "fractured" thermometer. The child is asymptomatic and their initial vital signs are: HR, 113 beats/minute; RR, 28 breaths/minute; T, 36.1 degrees Celsius. The physician calls the Poison Control Center seeking advice for work-up and treatment recommendations.







2.     An 85-year-old man with a past medical history of paroxysmal atrial fibrillation, hypothyroidism, heart block with permanent pacemaker, and urothelial cell carcinoma s/p left sided nephroureterectomy two months ago, currently receiving immunotherapy presents to the ED complaining of generalized weakness and difficulty walking. His initial vital signs are: BP, 100/72 mm Hg; HR, 87 beats/minute; RR; 18 breaths/minute; T, 98 degrees Fahrenheit; O2 Sat, 98% (RA). His ECG shows a ventricular paced rhythm at 87 beats/minute and his initial high sensitivity serum troponin T is elevated to 1231 ng/L.







3.     A 62-year-old man with a past medical history of end stage renal disease receiving routine weekly hemodialysis presents to the ED complaining of dizziness, weakness, fatigue and feeling like he's going to "pass out." He recently had a new medication added started by his dentist to treat him for presumed trigeminal neuralgia. His initial vital signs are: BP, 189/104 mm Hg; HR, 90 beats/minute; RR, 20 breaths/minute; T, 97.9 degrees Fahrenheit; O2 Sat, 96% (RA).








Mark K. Su, MD, MPH

Director, New York City Poison Control Center

Jointly Provided by the NYU Grossman School of Medicine and the Poison Control Center.


Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education through the joint providership of the NYU School of Medicine and the Poison Control Center. The NYU Grossman School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.



Credit Designation Statement

The NYU Grossman School of Medicine designates both of these as live activities for a maximum of 0.75 AMA PRA Category 1 CreditsTM for Toxicology Grand Rounds and 2 AMA PRA Category 1 CreditsTM for Consultants' Conference. Physicians should claim only the credit commensurate with the extent of their participation in the activity.



Disclosure Statement

The NYU Grossman School of Medicine adheres to ACCME accreditation requirements and policies, including the Standards for Commercial Support regarding industry support of continuing medical education. In order to resolve any identified Conflicts of Interest, disclosure information is provided during the planning process to ensure resolution of any identified conflicts. Disclosure of faculty and commercial relationships as well as the discussion of unlabeled or unapproved use of any drug, device or procedure by the faculty will be fully noted at the meeting.




Mark K Su, MD, MPH

Clinical Associate Professor of Emergency Medicine

The Ronald O. Perelman Department of Emergency Medicine

Director, New York City Poison Control

Email: mark.su at nyulangone.org<mailto:mark.su at nyulangone.org>

NYC PCC: 212-POISONS

[Twitter icon]@markksu1md



------------------------------------------------------------
This email message, including any attachments, is for the sole use of the intended recipient(s) and may contain information that is proprietary, confidential, and exempt from disclosure under applicable law. Any unauthorized review, use, disclosure, or distribution is prohibited. If you have received this email in error please notify the sender by return email and delete the original message. Please note, the recipient should check this email and any attachments for the presence of viruses. The organization accepts no liability for any damage caused by any virus transmitted by this email.
=================================
-------------- next part --------------
An HTML attachment was scrubbed...
URL: <http://lists.upstate.edu/pipermail/toxnews/attachments/20220404/16c0aed9/attachment-0001.html>